Literature DB >> 21078287

Evaluation of osteoclastic resorption activity using calcium phosphate coating combined with labeled polyanion.

Tatsuya Miyazaki1, Satoshi Miyauchi, Takahisa Anada, Hideki Imaizumi, Osamu Suzuki.   

Abstract

Osteoclasts are involved in bone resorption, and its activation is considered one of the causes of osteoporosis. The pit assay is the principal method for evaluating osteoclast function by measuring hydroxyapatite resorption in vitro. However, the pit assay requires time and trained techniques, including the pit image analysis, and there is no other easy method for evaluating bone resorption. In this study, we developed a novel approach to quantify the bone resorption activity using a calcium phosphate (CaP) coating labeled with fluorescent polyanion. Fluoresceinamine-labeled chondroitin polysulfate or Hoechst 33258-labeled deoxyribonucleic acid was used for CaP labeling. When macrophage cell line RAW264 was cultured on the labeled CaP under the stimulation with the receptor activator of the NF-κB ligand (RANKL), RAW264 cells differentiated into osteoclastic cells and the fluorescence intensity of the culture supernatant and pit area increased in a time- and dose-dependent manner. Furthermore, drugs for osteoporosis treatment, such as pamidronate and β-estradiol, inhibited fluorescein release by the cells stimulated with RANKL. A positive correlation between the fluorescence intensity and pit area was observed (r=0.917). These results indicated that this new method using fluorescent polyanion-labeled CaP is a standardized useful assay system for the evaluation of bone resorption activity. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21078287     DOI: 10.1016/j.ab.2010.11.014

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  11 in total

1.  Xanthine Derivative KMUP-1 Attenuates Experimental Periodontitis by Reducing Osteoclast Differentiation and Inflammation.

Authors:  Cheng-Hsiang Kuo; Ban-Hua Zhang; Shang-En Huang; Jong-Hau Hsu; Yan-Hsiung Wang; Thi Tuyet Ngan Nguyen; Chao-Han Lai; Jwu-Lai Yeh
Journal:  Front Pharmacol       Date:  2022-04-28       Impact factor: 5.988

2.  Resolvin E1 Inhibits Osteoclastogenesis and Bone Resorption by Suppressing IL-17-induced RANKL Expression in Osteoblasts and RANKL-induced Osteoclast Differentiation.

Authors:  Yoshihiro Funaki; Yasuyuki Hasegawa; Ryota Okazaki; Akira Yamasaki; Yuriko Sueda; Akihiro Yamamoto; Masaaki Yanai; Takehito Fukushima; Tomoya Harada; Haruhiko Makino; Eiji Shimizu
Journal:  Yonago Acta Med       Date:  2018-03-28       Impact factor: 1.641

3.  Wear particles derived from metal hip implants induce the generation of multinucleated giant cells in a 3-dimensional peripheral tissue-equivalent model.

Authors:  Debargh K Dutta; Pushya A Potnis; Kelly Rhodes; Steven C Wood
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

4.  Extensive protein expression changes induced by pamidronate in RAW 264.7 cells as determined by IP-HPLC.

Authors:  Sang Shin Lee; Soung Min Kim; Yeon Sook Kim; Suk Keun Lee
Journal:  PeerJ       Date:  2020-05-21       Impact factor: 2.984

5.  Inhibitory effects of low intensity pulsed ultrasound on osteoclastogenesis induced in vitro by breast cancer cells.

Authors:  Valeria Carina; Viviana Costa; Stefania Pagani; Angela De Luca; Lavinia Raimondi; Daniele Bellavia; Stefania Setti; Milena Fini; Gianluca Giavaresi
Journal:  J Exp Clin Cancer Res       Date:  2018-08-20

6.  The effect of lipoxin A4 on E. coli LPS-induced osteoclastogenesis.

Authors:  Muhanad Ali; Nathan Kucko; John A Jansen; Fang Yang; X Frank Walboomers
Journal:  Clin Oral Investig       Date:  2020-06-06       Impact factor: 3.573

7.  Pitavastatin slows tumor progression and alters urine-derived volatile organic compounds through the mevalonate pathway.

Authors:  Luqi Wang; Yue Wang; Andy Chen; Meghana Teli; Rika Kondo; Aydin Jalali; Yao Fan; Shengzhi Liu; Xinyu Zhao; Amanda Siegel; Kazumasa Minami; Mangilal Agarwal; Bai-Yan Li; Hiroki Yokota
Journal:  FASEB J       Date:  2019-10-04       Impact factor: 5.834

8.  Inductive Effect of Palmatine on Apoptosis in RAW 264.7 Cells.

Authors:  Shintaro Ishikawa; Misako Tamaki; Yui Ogawa; Kiyomi Kaneki; Meng Zhang; Masataka Sunagawa; Tadashi Hisamitsu
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-31       Impact factor: 2.629

9.  Effects of a checkpoint kinase inhibitor, AZD7762, on tumor suppression and bone remodeling.

Authors:  Luqi Wang; Yue Wang; Andy Chen; Aydin Jalali; Shengzhi Liu; Yunxia Guo; Sungsoo Na; Harikrishna Nakshatri; Bai-Yan Li; Hiroki Yokota
Journal:  Int J Oncol       Date:  2018-07-13       Impact factor: 5.650

10.  Effects of Erythromycin on Osteoclasts and Bone Resorption via DEL-1 Induction in Mice.

Authors:  Hikaru Tamura; Tomoki Maekawa; Hisanori Domon; Takumi Hiyoshi; Satoru Hirayama; Toshihito Isono; Karin Sasagawa; Daisuke Yonezawa; Naoki Takahashi; Masataka Oda; Takeyasu Maeda; Koichi Tabeta; Yutaka Terao
Journal:  Antibiotics (Basel)       Date:  2021-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.